番茄社区app

Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your 番茄社区app member benefits, participate in College activities, and engage with your 番茄社区app colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your 番茄社区app member benefits, participate in College activities, and engage with your 番茄社区app colleagues. It's all here.

Become a Member
番茄社区app
Literature Selections

Robotic Pancreaticoduodenectomy Holds Several Benefits Over Open and Laparoscopic Approaches

Selection prepared by Christopher DuCoin, MD, MPH, F番茄社区app

January 6, 2026

acs-store-journalperiodical.jpg

Ikenaga N, Kumamaru H, Inomata M, et al. . Ann Surg. December 2025.

This propensity matched study evaluated short-term outcomes of robotic pancreaticoduodenectomy (RPD) compared with open (OPD) and laparoscopic pancreaticoduodenectomy (LPD) using the Japanese National Clinical Database (NCD), which captures >95% of surgical procedures in that country. 

Among 58,531 PDs performed 2019鈥2023, 46,166 cases met eligibility criteria after excluding complex resections not suitable for robotic surgery. To ensure baseline institutional proficiency, analyses were restricted to centers performing 鈮20 PDs/year, yielding 20,898 OPD, 1,378 LPD, and 1,337 RPD cases. Propensity score matching generated 1,248 RPD鈥揙PD pairs and 1,066 RPD鈥揕PD pairs with balanced baseline characteristics.

RPD was associated with a significantly lower rate of severe postoperative complications (Clavien鈥揇indo 鈮II) compared with OPD (22.2% vs. 25.9%; OR 0.82, 95% CI 0.68鈥0.98; p = 0.031). Clinically relevant postoperative pancreatic fistula was reduced (19.3% vs. 24.5%; p = 0.002), and major blood loss was less frequent (4.8% vs. 12.7%; p <0.001). Median postoperative length of stay was 5 days shorter with RPD (19 days vs. 24 days; p <0.001). These benefits occurred despite substantially longer operative time (603 min. vs. 422 min.; p <0.001). In-hospital mortality was low and comparable (0.7% RPD vs. 0.8% OPD).聽

Notably, deep venous thrombosis (DVT) occurred more often after RPD (1.9% vs. 0.8%; OR 2.43; p = 0.016), and 30-day readmission was higher (4.3% vs. 2.2%; p = 0.004). Volume-stratified analyses showed that reductions in severe complications were concentrated in high-volume centers (鈮50 PDs/year).

Compared with LPD, RPD demonstrated a lower incidence of severe complications (23.0% vs. 27.6%; OR 0.78, 95% CI 0.64鈥0.95; p = 0.015) and clinically relevant pancreatic fistula (19.3% vs. 25.4%; p = 0.001). Conversion to open surgery was significantly reduced with RPD (3.5% vs 6.9%; OR 0.48; p <0.001), while blood loss >1,000 mL was similar (~5%). Operative time again favored LPD (612 vs. 524 min; p <0.001). Postoperative length of stay was marginally shorter (19 days vs. 20 days; p = 0.01), with no difference in mortality (~0.7%) or readmission.聽

DVT remained more frequent with RPD (2.1% vs 0.7%; OR 3.18; p = 0.005), particularly in lower-volume centers.

Overall, RPD was associated with improved short-term outcomes, including lower severe morbidity, fewer pancreatic fistulas, reduced blood loss, and shorter hospitalization, compared with both open and laparoscopic approaches鈥攁t the cost of longer operative times and a higher incidence of DVT.

Benefits were most pronounced in high-volume centers. The increased thromboembolic risk highlights the need for aggressive perioperative thromboprophylaxis and vigilance, particularly during prolonged robotic procedures. Long-term oncologic outcomes and cost-effectiveness were not assessed and remain key areas for future investigation.